Monthly Archives: October 2015

Featured Stories

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports. According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Nursing Home Abuse Lawsuit Filed after Strangulation Death

Nursing Home Abuse Lawsuit Filed after Strangulation Death

There are questions of abuse and neglect surrounding the death of a nursing home resident in North Carolina. According to Star News Online, Mary Bowling was an 89-year-old widow at Carolina Rivers Nursing and Rehabilitation Center. Her death certificate and … Continue reading

Posted in Legal News | Tagged , , , , |

European Medicines Agency Seeks Market Suspension of Medtronic InductOs

Euro Medicines Agency Seeks Suspension of Medtronic InductOs

The European Union’s medical device regulator has recommended suspension of the marketing authorization for Medtronic’s InductOs bone growth device until issues at a U.S. plant that makes a component of the device are resolved. The European Medicines Agency (EMA) launched … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , , , |

Texas Compounding Pharmacy Recalls Possibly Contaminated Sterile Drug Products

Texas Compounding Pharmacy Recalls Contaminated Products

A Dallas, Texas compounding pharmacy that has previously been cited for safety issues by the Food and Drug Administration (FDA), once again faces problems with the federal drug regulator. Downing Labs in Farmers Branch was cited for failing to investigate … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , |

Device Used During Surgery Linked to 8 Infections, 4 Deaths at PA Hospital

Device Used During Surgery Linked to 8 Infections, 4 Deaths

A device used to heat and cool a patient’s blood during heart surgery has been linked to infections in 8 patients at a Pennsylvania hospital. The New York Times reports that four of those patients have died, but it is … Continue reading

Posted in Defective Medical Devices, Legal News | Tagged , , , , |

Invokana Increases Risk of Bone Fractures, FDA Warns

Invokana Increases Risk of Bone Fractures

The Food and Drug Administration (FDA) issued a safety announcement in September warning patients and health care providers of an increased risk of bone fractures in patients taking the type 2 diabetes drugs Invokana and Invokamet (canagliflozin). The FDA deemed … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , |

FDA Requires Drug Interaction Studies for Kayexalate

FDA Requires Drug Interaction Studies for Kayexalate

The Food and Drug Administration (FDA) is requiring the manufacturer of the potassium-lowering drug Kayexalate to conduct studies to investigate Kayexalate’s potential to affect how other medications work. The approved labeling for Kayexalate (sodium polystyrene sulfonate) describes its potential to … Continue reading

Posted in Legal News, Pharmaceuticals | Tagged , , , |

Popular Acid Reflux Medications Associated with Serious Side Effects

Popular Acid Reflux Medications

Protein pump inhibitors, a class of widely used acid reflux medications that includes Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole). can have serious side effects. Dr. Shoshana J. Herzig of Harvard Medical School told the New York Times that they … Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals | Tagged , , , , |

Due to Fire Risk, Toyota Recalls 6.5M Cars

Due to Fire Risk, Toyota Recalls 6.5M Cars

Due to a defect in the driver’s side window that presents a fire hazard, Toyota is recalling 6.5 million vehicles. The recall affects roughly 2 million cars in the US. The problem is that the power-window master switch may have … Continue reading

Posted in Legal News, Product Recalls, Toyota Recall | Tagged , , , , |

Does the Flu Vaccine Carry Risks?

Does the Flu Vaccine Carry Risks?

As flu season is upon us, some may wonder whether there are any risks associated with getting the flu vaccine. This is addressed in a recent New York Times Ask Well blog, which responds to a reader question that asks … Continue reading

Posted in Health Concerns, Legal News | Tagged , , , |

FDA Updates Contraindications for Myrbetriq

FDA Updates Contraindications for Myrbetriq

The U.S. Food and Drug Administration (FDA) has updated the label on Myrebetriq to include a new contraindication and additional information in the Warnings and Precautions section. The revised label now states that the drug, which is used to treat … Continue reading

Posted in Legal News | Tagged , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.